# Pennant Group, Inc.: overview

PNTG · Nasdaq · CIK 1766400 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pntg.md) · [Financials](/companies/pntg/financials.md) · [Filings](/companies/pntg/filings.md) · [Insiders](/companies/pntg/insiders.md)

Latest reported revenue: [$298.0m](/filings/0001766400-26-000065.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 5, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001766400-26-000065).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [181](/filings/0001766400-25-000139.md) | [189 d](/filings/0001766400-26-000014.md) | [210](/filings/0001766400-26-000054.md) | [220](/filings/0001766400-26-000065.md) | [229](/filings/0001766400-25-000139.md) | [289 d](/filings/0001766400-26-000014.md) | [285](/filings/0001766400-26-000054.md) | [298](/filings/0001766400-26-000065.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [6.0%](/filings/0001766400-25-000139.md) | [4.9% d](/filings/0001766400-26-000014.md) | [6.0%](/filings/0001766400-26-000054.md) | [5.3%](/filings/0001766400-26-000065.md) | [4.5%](/filings/0001766400-25-000139.md) | [6.0% d](/filings/0001766400-26-000014.md) | [6.1%](/filings/0001766400-26-000054.md) | [5.8%](/filings/0001766400-26-000065.md) |
| Net margin | % | [3.4%](/filings/0001766400-25-000139.md) | [3.0% d](/filings/0001766400-26-000014.md) | [3.7%](/filings/0001766400-26-000065.md) | [3.2%](/filings/0001766400-26-000065.md) | [2.7%](/filings/0001766400-25-000139.md) | [3.0% d](/filings/0001766400-26-000014.md) | [3.0%](/filings/0001766400-26-000065.md) | [3.0%](/filings/0001766400-26-000065.md) |
| Diluted EPS | $ per share | [0.20](/filings/0001766400-25-000139.md) | not reported | [0.22](/filings/0001766400-26-000054.md) | [0.20](/filings/0001766400-26-000065.md) | [0.17](/filings/0001766400-25-000139.md) | not reported | [0.24](/filings/0001766400-26-000054.md) | [0.25](/filings/0001766400-26-000065.md) |
| Free cash flow | $m | [6.8 d](/filings/0001766400-25-000139.md) | [17.2 d](/filings/0001766400-26-000014.md) | [(23.2)](/filings/0001766400-26-000054.md) | [31.6 d](/filings/0001766400-26-000065.md) | [10.5 d](/filings/0001766400-25-000139.md) | [17.4 d](/filings/0001766400-26-000014.md) | [(8.7)](/filings/0001766400-26-000054.md) | [15.5 d](/filings/0001766400-26-000065.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [440](/filings/0001766400-24-000022.md) | [473](/filings/0001766400-25-000024.md) | [545](/filings/0001766400-26-000014.md) | [695](/filings/0001766400-26-000014.md) | [948](/filings/0001766400-26-000014.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [1.1%](/filings/0001766400-24-000022.md) | [2.7%](/filings/0001766400-25-000024.md) | [4.6%](/filings/0001766400-26-000014.md) | [5.5%](/filings/0001766400-26-000014.md) | [5.5%](/filings/0001766400-26-000014.md) |
| Net margin | % | [0.6%](/filings/0001766400-24-000022.md) | [1.4%](/filings/0001766400-25-000024.md) | [2.5%](/filings/0001766400-26-000014.md) | [3.2%](/filings/0001766400-26-000014.md) | [3.1%](/filings/0001766400-26-000014.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001766400-24-000022.md) | [0.22](/filings/0001766400-25-000024.md) | [0.44](/filings/0001766400-26-000014.md) | [0.70](/filings/0001766400-26-000014.md) | [0.84](/filings/0001766400-26-000014.md) |
| Free cash flow | $m | [(24.5)](/filings/0001766400-24-000022.md) | [(5.1)](/filings/0001766400-25-000024.md) | [25.0](/filings/0001766400-26-000014.md) | [30.3](/filings/0001766400-26-000014.md) | [36.3](/filings/0001766400-26-000014.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pntg/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $109.3m | 2,959,141 |  | Added +243,076 |
| [WASATCH ADVISORS LP](/funds/814133.md) | 2026-06-30 | $69.1m | 1,870,178 |  | Added +451,491 |
| [TURTLE CREEK ASSET MANAGEMENT INC.](/funds/1484148.md) | 2026-06-30 | $63.3m | 1,714,462 |  | Added +131,639 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $54.7m | 1,480,881 |  | Added +29,913 |
| [PARADIGM CAPITAL MANAGEMENT INC/NY](/funds/1037792.md) | 2026-06-30 | $51.8m | 1,402,800 |  | Reduced −6,000 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $43.7m | 1,182,138 |  | Added +79,514 |
| [Provident Investment Management, Inc.](/funds/1076964.md) | 2026-06-30 | $34.7m | 939,208 |  | Reduced −43,807 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $32.9m | 891,426 |  | Added +260,035 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $32.8m | 886,783 |  | Added +44,645 |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $32.3m | 874,745 |  | Added +2,560 |

## Recent filings

[All 531 filings](/companies/pntg/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:20 ET | [10-Q](/filings/0001766400-26-000065.md) | Quarterly report, period 2026-06-30 | 0001766400-26-000065 |
| 2026-08-05 | 16:16 ET | [8-K](/filings/0001766400-26-000064.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000064 |
| 2026-05-20 | 16:02 ET | [8-K](/filings/0001766400-26-000056.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001766400-26-000056 |
| 2026-05-06 | 16:09 ET | [10-Q](/filings/0001766400-26-000054.md) | Quarterly report, period 2026-03-31 | 0001766400-26-000054 |
| 2026-05-06 | 16:07 ET | [8-K](/filings/0001766400-26-000053.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000053 |
| 2026-03-31 | 16:05 ET | [DEF 14A](/filings/0001766400-26-000027.md) | Proxy statement, period 2026-05-14 | 0001766400-26-000027 |
| 2026-02-26 | 08:05 ET | [10-K](/filings/0001766400-26-000014.md) | Annual report, period 2025-12-31 | 0001766400-26-000014 |
| 2026-02-25 | 16:25 ET | [8-K](/filings/0001766400-26-000011.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001766400-26-000011 |
| 2025-12-17 | 19:02 ET | [8-K/A](/filings/0001766400-25-000147.md) | 9.01 Financial statements and exhibits | 0001766400-25-000147 |
| 2025-11-05 | 16:32 ET | [8-K](/filings/0001766400-25-000141.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001766400-25-000141 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001766400-26-000014.md), filed Feb 26, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/234618a4-6c29-487e-b215-76d105ddc015)

## About the filer

- CIK: 1766400
- Tickers: PNTG
- Exchange: Nasdaq
- SIC code: 8000 Services-Health Services
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 12:38 ET. No prices; not investment advice.